Notes And Other Explanatory Information [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166255

Concept 2022-01-01 to
2022-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]
3
Disclosure of auditors' remuneration [text block]
30
Disclosure of authorisation of financial statements [text block]
The consolidated financial statements were authorised
Disclosure of basis of consolidation [text block]
2
Disclosure of basis of preparation of financial statements [text block]
2
Disclosure of borrowings [text block]
15
Disclosure of cash and cash equivalents [text block]
13
Disclosure of changes in accounting policies, accounting estimates and errors [text block]
Relevant IFRS accounting pronouncements adopted
Disclosure of commitments [text block]
27
Disclosure of commitments and contingent liabilities [text block]
26
Disclosure of credit risk [text block]
4
Disclosure of deferred taxes [text block]
17
Disclosure of depreciation and amortisation expense [text block]
(in € thousand)
Disclosure of derivative financial instruments [text block]
In 2022, the Group actively mitigated its foreign
Disclosure of earnings per share [text block]
24
Disclosure of effect of changes in foreign exchange rates [text block]
4
Disclosure of entity's operating segments [text block]
5
Disclosure of events after reporting period [text block]
29
Disclosure of expenses by nature [text block]
19
Disclosure of financial instruments [text block]
4
Disclosure of financial instruments at fair value through profit or loss [text block]
4
Disclosure of financial risk management [text block]
4
Disclosure of general information about financial statements [text block]
1
Disclosure of going concern [text block]
3
Disclosure of income tax [text block]
23
Disclosure of information about employees [text block]
20
Disclosure of information about key management personnel [text block]
28
Disclosure of intangible assets [text block]
7
Disclosure of interest income [text block]
22
Disclosure of investments accounted for using equity method [text block]
9
Disclosure of investments other than investments accounted for using equity method [text block]
10
Disclosure of issued capital [text block]
Share Capital
Disclosure of leases [text block]
8
Disclosure of liquidity risk [text block]
5
Disclosure of objectives, policies and processes for managing capital [text block]
14
Disclosure of other liabilities [text block]
15
Disclosure of other operating income (expense) [text block]
Expenses by nature represent an alternative disclosure
Disclosure of other operating income [text block]
21
Disclosure of prepayments and other assets [text block]
12
Disclosure of related party [text block]
28
Disclosure of reserves within equity [text block]
Other reserves
Disclosure of revenue [text block]
18
Disclosure of information about separate financial statements [text block]
Statement of Financial Position
Disclosure of share capital, reserves and other equity interest [text block]
14
Disclosure of share-based payment arrangements [text block]
25
Disclosure of subsidiaries [text block]
6
Disclosure of tax receivables and payables [text block]
23
Disclosure of trade and other payables [text block]
16
Disclosure of trade and other receivables [text block]
11

Talk to a Data Expert

Have a question? We'll get back to you promptly.